Evaluation of Pilgrims Hospices rapid response community end of life service in East Kent

ISRCTN ISRCTN32119670
DOI https://doi.org/10.1186/ISRCTN32119670
Secondary identifying numbers 9051
Submission date
22/06/2012
Registration date
22/06/2012
Last edited
24/06/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
In England over half a million people die each year and while most people would prefer to die at home, many are not able to do so and more than half die in hospitals. This study will investigate a new rapid response hospice at home service which aims to support patients under hospice care to die in their preferred place. The aim of the study is to provide evidence on the outcomes and costs of rapid response hospice at home teams. The objectives are to assess the impact of the service on:
1. Patients' preference - whether the service enables more patients to die in their preferred place.
2. Carers' quality of life during and after death.
3. The relative costs and consequences of a rapid response hospice at home team compared with usual services.
4. A 'good death'.

Who can participate?
The study will monitor the actual and preferred place of death for 441 newly referred patients to the hospice. We will recruit 504 carers to complete postal questionnaires on quality of life, well-being and caring activities. We will also carry out up to 60 interviews with bereaved carers about the patient’s end of life experience.

What does the study involve?
The intervention to be tested is a rapid response hospice at home service. The main features of the service are that it:
1. Is available to patients in their own home (including care homes).
2. Has a robust ‘hospice standard’ assessment which takes account of: patient preferences, carer/family preferences, patient needs and patient prognosis.
3. Provides hands-on care.
4. Responds rapidly to crises using human and material resources available 24/7 with access to health care assistants, a service coordinator, palliative care nursing, medical advice, and small pieces of equipment which can be carried by car.
5. Works in coordination with other community services.
The hospice operates from three sites covering separate catchment areas. Each site will be randomly allocated to the order in which it will receive the service, with the first site starting with the service and the others offering it after 6 and 12 months, respectively. All patients will be eligible to access the service when it is offered in their area. Sites which do not yet have the service will continue to offer usual services.

What are the possible benefits and risks of participating?
There are no specific benefits or risks to participants as patients and carers will still be able to access the full range of hospice services, including hospice at home if they do not participate.

Where is the study run from?
The study is run from Pilgrims Hospices in East Kent, in collaboration with the Universities of Kent and Surrey and sponsored by East Kent Hospitals University NHS Foundation Trust.

When is the study starting and how long is it expected to run for?
The study started in December 2009 and will run until October 2012. Participants will be recruited for 2 years.

Who is funding the study?
National Institute for Health Research (NIHR)

Who is the main contact?
Dr Claire Butler, Pilgrims Hospices, claire.butler@pilgrimshospices.org
Laura Holdsworth, University of Kent, l.m.holdsworth@kent.ac.uk

Contact information

Mrs Rose Ward
Scientific

East Kent Hospitals EKHUFT
c/o Pilgrims Hospice 56 London Road
Canterbury
CT2 8JA
United Kingdom

Phone +44 (0)1227 459700
Email rose_ward@pilgrimshospice.org

Study information

Study designQuasi-experimental multi-centre controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEvaluation of Pilgrims Hospices rapid response community end of life service in East Kent: A Quasi-experimental multi-centre controlled trial
Study hypothesisThe quantitative evaluation is a pragmatic quasi-experimental multi-centre controlled trial, with an embedded cost evaluation. The study also includes a qualitative evaluation using in-depth interviews to explore carers' perceptions.

The aim of the study is to contribute to the development of the evidence base on the outcomes and costs of rapid response hospice at home teams.

The main hypothesis to be tested is that the rapid response service will significantly increase the number of patients who die in their initial preferred place of death compared to the control group of patients who receive usual services. Related hypotheses to be tested are that:
1) The rapid response service improves the quality of life of carers of patients in the intervention compared to carers in the control group
2. The overall cost of providing care for patients in the intervention group is not significantly different to the cost of providing care for patients in the control group. In addition the study will contribute to generating a hypothesis on the ways in which carers perceive the quality of care and judge a 'good death.
Ethics approval(s)NRES Committee South East Coast –Kent, 09-H1101-75; First MREC approval date 22/12/2009
ConditionTopic: National Cancer Research Network, Generic Health Relevance and Cross Cutting Themes; Subtopic: All Cancers/Misc Sites, Generic Health Relevance (all Subtopics); Disease: All, Health Services Research
InterventionHospice at home, The main features of the intervention are that it:
1. Is available to patients in their own home
2. Has a robust ‘hospice standard’ assessment
3. Provides hands on care
4. Responds rapidly to crises using human and material resources available 24/7 and
5. Works in coordination with other community services
Intervention typeOther
Primary outcome measurePatient preferred place of death
Secondary outcome measures1. Carer quality of life and well-being - Carer outcomes will be measured at baseline on patient intake and 8 months later using self completion postal questionnaires. The outcome measures included in the questionnaire are the short-form SF12, measure of anxiety and depression (HADS), a measure of health utility (EQ-5D), and caregiving demand measured at baseline only.
2. Cost evaluation
Overall study start date01/01/2010
Overall study end date31/01/2012

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsPlanned Sample Size: 1005; UK Sample Size: 1005; Description: 441 patients, 504 carers for questionnaires, 60 bereaved carers for interviews
Participant inclusion criteria1. All patients referred to the Pilgrims Hospices during the study and who die during the data collection period will be entered into the study.
2. All carers and bereaved carers who are able to consent will be eligible to participate.
3. Target Gender: Male & Female ; Lower Age Limit 18 years
Participant exclusion criteriaCarers and bereaved carers not capable of giving consent
Recruitment start date01/01/2010
Recruitment end date31/01/2012

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

East Kent Hospitals EKHUFT
Canterbury
CT2 8JA
United Kingdom

Sponsor information

East Kent Hospitals NHS Trust (UK)
Hospital/treatment centre

Ethelbert Road
Canterbury
CT1 3NG
England
United Kingdom

ROR logo "ROR" https://ror.org/02dqqj223

Funders

Funder type

Government

National Institute for Health Research (NIHR (UK) - Research for Patient Benefit Programme, Grant: PB-PG-0808-16126

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2015 Yes No
Results article results 01/10/2015 Yes No
Results article results 23/12/2015 Yes No

Editorial Notes

24/06/2016: Publication references added.
14/01/2016: Publication reference added.